Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (human)
SUBMITTER: Yong Zhang
LAB HEAD: Yong Zhang
PROVIDER: PXD026333 | Pride | 2022-08-12
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
HC-Result.rar | Other | |||
HC1.raw | Raw | |||
HC2.raw | Raw | |||
HC3.raw | Raw | |||
HC4.raw | Raw |
Items per page: 5 1 - 5 of 32 |
Liu Chang-Hai CH Zheng Shanshan S Wang Shisheng S Wu Dongbo D Jiang Wei W Zeng Qingmin Q Wei Yi Y Zhang Yong Y Tang Hong H
Diagnostics (Basel, Switzerland) 20220607 6
Background: In patients with metabolic-associated fatty liver disease (MAFLD), hepatic steatosis is the first step of diagnosis, and it is a risk predictor that independently predicts insulin resistance, cardiovascular risk, and mortality. Urine biomarkers have the advantage of being less complex, with a lower dynamic range and fewer technical challenges, in comparison to blood biomarkers. Methods: Hepatic steatosis was measured by magnetic resonance imaging (MRI), which measured the proton dens ...[more]